Metraipolis › archive › dc_100b4823ae43
El Agente Fármaco: A Scalable AI Scientist for Drug Discovery — arXiv:2611.03832
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2611.03832
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-04T18:32:22.985Z
- SHA-256 of the archived text
61d17950b7e6ac778e580de26b54293a63751676ba40e14ce211bd5a6e559bf6- Stable URL of this page
https://metraipolis.com/documento/dc_100b4823ae43
How to cite
El Agente Fármaco: A Scalable AI Scientist for Drug Discovery — arXiv:2611.03832 — arXiv (en), https://arxiv.org/abs/2611.03832 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_100b4823ae43 (Metraipolis archive dc_100b4823ae43, sha256 61d17950b7e6ac778e580de26b54293a63751676ba40e14ce211bd5a6e559bf6)
BibTeX
@misc{dc100b4823ae43,
title = {El Agente Fármaco: A Scalable AI Scientist for Drug Discovery — arXiv:2611.03832},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2611.03832},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_100b4823ae43; sha256 61d17950b7e6ac778e580de26b54293a63751676ba40e14ce211bd5a6e559bf6},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2611.03832. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente Fármaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: Fármaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM decision for every compound. This design limits the information the model must process as screening collections grow, while keeping the underlying results available for inspection and further analysis. The integrated tools support molecule generation, prediction of binding and molecular properties, and searches for compounds available for purchase. In a retrospective comparison with an expert-led campaign, the agent proposed chemically distinct candidates with competitive docking scores and higher calculated drug-likeness under explicitly imposed selection criteria. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, with lower median cumulative token use and peak context. Fármaco provides a foundation for flexible, scalable drug discovery workflows that connect scientific reasoning with an enduring, traceable record of computational work. Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.MA, nuovi lavori del giorno). Categorie arXiv: Artificial Intelligence (cs.AI) ; Multiagent Systems (cs.MA); Biomolecules (q-bio.BM). Pagina del lavoro: https://arxiv.org/abs/2611.03832 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-11-04T18:32:22.196Z dalla pagina https://arxiv.org/list/cs.MA/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).